IPP Bureau
OneSource Specialty Pharma strengthens its board by appointing new directors
By IPP Bureau - March 13, 2025
These appointments align with the group’s philosophy of having a strong and independent board with exceptional industry experts, ensuring strategic guidance and effective governance
Glenmark Pharma launches Empagliflozin and its fixed-drug combinations in India
By IPP Bureau - March 13, 2025
Empagliflozin and its Fixed Drug Combinations (FDCs) have been launched under the brand names Glempa, Glempa –L and Glempa-M
Alkem launches generic empagliflozin and its combinations in India under ‘Empanorm’
By IPP Bureau - March 13, 2025
Empagliflozin is used in the treatment of type-2 diabetes mellitus, chronic kidney disease and heart failure
Zydus receives final approval from USFDA for Methenamine Hippurate Tablets USP, 1 gram
By IPP Bureau - March 13, 2025
Methenamine Hippurate tablets are indicated for prophylactic or suppressive treatment of frequently recurring urinary tract infections
Zynext Ventures invests in Illexcor Therapeutics to advance novel oral therapy for sickle cell disease
By IPP Bureau - March 13, 2025
Illexcor is developing a first-in-class oral drug that directly targets the root cause of SCD
Sigachi Industries signs MoU with INS Kalinga to promote healthy living
By IPP Bureau - March 13, 2025
The programme will take place on the 2nd Sunday of every month
Poly Medicure receives MDR certification for 54 products
By IPP Bureau - March 12, 2025
The MDR certification reafirms that these products meet the highest safety, quality, and regulatory standards
Zydus to acquire majority stake in Amplitude Surgical, France
By IPP Bureau - March 12, 2025
Amplitude Surgical is a European MedTech leader in high-quality, lower-limb orthopaedic technologies
Senores Pharmaceuticals to increase stake in Havix to 54.96%
By IPP Bureau - March 12, 2025
Havix was incorporated under the laws of the State of Delaware on February 17, 2015
Nectar Lifesciences receives 7 observations from EDQM for API facility
By IPP Bureau - March 12, 2025
The European regulator will conduct a re-inspection of the facility to verify the compliance
UFlex secures USFDA approval for recycled PE in food packaging
By IPP Bureau - March 12, 2025
Announces Rs. 317 crore investment in new recycling plant
Aster DM Healthcare promoters reduce share pledge from 99% to 41%
By IPP Bureau - March 12, 2025
The new lenders – JP Morgan, HSBC, and Barclays provided fresh funding
CCRH and Adamas University sign MoU to advance homoeopathy research
By IPP Bureau - March 12, 2025
This MoU marks a significant milestone in interdisciplinary research, paving the way for scientific advancements in homoeopathy
atulya celebrates International Women’s Day
By IPP Bureau - March 12, 2025
Encourages working women to practice self-care
Syngene acquires first US biologics facility for $36.5 million
By IPP Bureau - March 11, 2025
Overall investment in the US facility is estimated around US$50 million
